Phase 2 Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Condition:   Cytomegalovirus Disease Interventions:   Drug: NPC-21 Low dose;   Drug: NPC-21 High dose;   Drug: NPC-21 Placebo Sponsor:   Nobelpharma Not yet recruiting

Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials